NasdaqGM - Nasdaq Real Time Price
USD
ADMA Biologics, Inc. (ADMA)
13.21
+2.73
(+26.05%)
At close: November 5 at 4:00:01 PM EST
13.11
-0.10
(-0.76%)
Pre-Market: 8:10:05 AM EST
Trade ADMA on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreInsider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| ELMS STEVEN A Director |
Purchase | Mar 6, 2026 | -- |
| FINGER ALISON CECILY Director |
Stock Award(Grant) | Feb 9, 2026 | 45,619 |
| GROSSMAN ADAM S Chief Executive Officer |
Conversion of Exercise of derivative security | Nov 5, 2026 | 3,795,160 |
| GROSSMAN JERROLD B Director |
Purchase | May 27, 2026 | 612,991 |
| GUIHEEN LAWRENCE P Director |
Stock Gift | Mar 17, 2026 | 186,510 |
| KESTENBERG-MESSINA KAITLIN M. Officer |
Conversion of Exercise of derivative security | Mar 9, 2026 | 466,600 |
| KOHLER TERRY Chief Financial Officer |
Stock Award(Grant) | Jul 16, 2026 | 143,149 |
| KWON YOUNG T. PH.D. Director |
Stock Award(Grant) | Feb 9, 2026 | 263,020 |
| SALAS EDUARDO RENE Director |
Stock Award(Grant) | Feb 9, 2026 | 21,579 |
| TADE BRAD L Chief Financial Officer |
Stock Award(Grant) | Feb 19, 2025 | 261,660 |
